Researcher: ‘We Made a Big Mistake’ [On Purpose] on ‘Covid’ Fake Vaccine

The more we learn about the COVID-19 vaccines, the worse they look. In a recent interview[1] with Alex Pierson (above), Canadian immunologist and vaccine researcher Byram Bridle, Ph.D., dropped a shocking truth bomb that immediately went viral, despite being censored by Google.

It also was featured in a “fact” check by The Poynter Institute’s Politifact,[2] which pronounced Bridle’s findings as “false” after interviewing Dr. Drew Weissman,[3] a UPenn scientist who is credited with helping to create the technology that enables the COVID mRNA vaccines to work. But, as you can see below, unlike Bridle, Politifact neglected to go beyond interviewing someone with such a huge stake in the vaccine’s success.

In 2020, Bridle was awarded a $230,000 government grant for research on COVID vaccine development. As part of that research, he and a team of international scientists requested a Freedom of Information Act (FOIA) access to Pfizer’s biodistribution study from the Japanese regulatory agency. The research,[4] [5]previously unseen, demonstrates a huge problem with all COVID-19 vaccines.

“We made a big mistake,” Bridle says. “We thought the spike protein was a great target antigen; we never knew the spike protein itself was a toxin and was a pathogenic protein. So, by vaccinating people we are inadvertently inoculating them with a toxin.”

Pfizer Omitted Industry-Standard Safety Studies

What’s more, TrialSite News reports[6] that Pfizer documents submitted to the European Medicines Agency [EMA] reveal the company “did not follow industry-standard quality management practices during preclinical toxicology studies … as key studies did not meet good laboratory practice (GLP).”

Read More: Researcher: ‘We Made a Big Mistake’ on COVID-19 Vaccine

Read more Lastest News at Philtoday.info

Leave a Reply

Your email address will not be published.

Previous post The WHO is changing their International Health Regulations…& that’s NOT good
Next post Pfizer CEO Albert Bourla explains Pfizer’s new tech to Davos crowd: “ingestible pills” – a pill with a tiny chip that send a wireless signal to relevant authorities when the pharmaceutical has been digested. “Imagine the compliance,” he says